Depression would be cost-effectively decreased in teens by Vitamin D (Iran) – July 2023

---

Is vitamin D supplementation program in Iranian schools effective in reducing adolescent depressive symptoms? Cost effectiveness study

BMC Public Health . 2023 Jul 20;23(1):1393. doi: 10.1186/s12889-023-16244-z. PDF behind paywall
Seyed Vahid Jasemi 1, Zhale Zandieh 2, Narges Zandieh 1, Mohsen Rezaei Hemami 3, Ali Darvishi 4 5, Zahra Abdollahi 6, Ramin Heshmat 7

Purpose: We aimed to assess the cost-effectiveness of the vitamin D supplementation program in Iranian adolescents reducing adolescent depressive Symptoms.

Methods: In the current cost-effectiveness analysis, the viewpoint of Iran's Ministry of Health was selected. The target population was 1,519,762 Iranian high school students (733,657 girls and 786,105 boys). The total costs of the vitamin D supplementations program were based on the reports of the Nutrition Improvement Office of Iran's Ministry of Health and were adjusted to 2018. The variable of Quality-Adjusted Life Years (QALYs) was considered a suitable variable for estimating the effectiveness of vitamin D supplementation. We chose one year as the time horizon. A decision tree model was constructed in TreeAge Pro. The results of the cost-effectiveness analysis were reported in term of the Incremental Cost-Effectiveness Ratio (ICER).

Results: The results of our study showed that the estimated cost per QALY gained of the vitamin D supplementation program is equal to 1528.6676 $, which indicates that vitamin D supplementation in adolescents(11-18Y) is a cost-effective and a dominant strategy in preventing depression through the cost-saving and QALYs increment compared to the no intervention. Sensitivity analysis showed that the possible variations in vitamin D supplement costs could not alter the results, and vitamin D supplementation may be a predominant and cost-effective strategy to prevent adulthood depression with a 100% probability.

Conclusion: The national program of vitamin D supplementation among Iranian adolescents was a cost-efficient strategy reducing adolescent depressive Symptoms through the cost-saving and QALYs increment compared to the no intervention.

38 References

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (London, England). 2006;367(9524):1747–57. - DOI - PubMed
2. Ustün TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry. 2004;184:386–92. - DOI - PubMed
3. Reddy MS. Depression: the disorder and the burden. Indian J Psychol Med. 2010;32(1):1–2. - DOI - PubMed - PMC
4. WHO. The global burden of disease: 2004 update. World Health Organization; 2008. https://apps.who.int/iris/handle/10665/43942 .
5. WHO. Depression. 2020. https://www.whoint/news-room/fact-sheets/detail/depression . Accessed 2 May 2021.
6. Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119–38. - DOI - PubMed - PMC
7. Milaneschi Y, Hoogendijk W, Lips P, Heijboer AC, Schoevers R, van Hemert AM, et al. The association between low vitamin D and depressive disorders. Mol Psychiatry. 2014;19(4):444–51. - DOI - PubMed
8. Vellekkatt F, Menon V. Efficacy of vitamin D supplementation in major depression: a meta-analysis of randomized controlled trials. J Postgrad Med. 2019;65(2):74–80. - PubMed - PMC
9. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21–30. - DOI - PubMed
10. Fernandes de Abreu DA, Eyles D, Eyles D, Féron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology. 2009;34(1):S265-77. - DOI - PubMed
11. Geng C, Shaikh AS, Han W, Chen D, Guo Y, Jiang P. Vitamin D and depression: mechanisms, determination and application. Asia Pac J Clin Nutr. 2019;28(4):689–94. - PubMed
12. Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013;202:100–7. - DOI - PubMed
13. Armstrong DJ, Meenagh GK, Bickle I, Lee AS, Curran ES, Finch MB. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol. 2007;26(4):551–4. - DOI - PubMed
14. Libuda L, Timmesfeld N, Antel J, Hirtz R, Bauer J, Führer D, et al. Effect of vitamin D deficiency on depressive symptoms in child and adolescent psychiatric patients: results of a randomized controlled trial. Eur J Nutr. 2020;59(8):3415–24. - DOI - PubMed - PMC
15. Bahrami A, Mazloum SR, Maghsoudi S, Soleimani D, Khayyatzadeh SS, Arekhi S, et al. High dose vitamin D supplementation is associated with a reduction in depression score among adolescent girls: a nine-week follow-up study. J Dietary Suppl. 2018;15(2):173–82. - DOI
16. Tartagni M, Cicinelli MV, Tartagni MV, Alrasheed H, Matteo M, Baldini D, et al. Vitamin D supplementation for premenstrual syndrome-related mood disorders in adolescents with severe hypovitaminosis D. J Pediatr Adolesc Gynecol. 2016;29(4):357–61. - DOI - PubMed
17. Tabrizi R, Moosazadeh M, Akbari M, Dabbaghmanesh MH, Mohamadkhani M, Asemi Z, et al. High prevalence of vitamin D deficiency among Iranian population: a systematic review and meta-analysis. Iran J Med Sci. 2018;43(2):125–39. - PubMed - PMC
18. Heshmat R, Mohammad K, Majdzadeh S, Forouzanfar M, Bahrami A, Ranjbar Omrani G, et al. Vitamin D deficiency in Iran: A multi-center study among different urban areas. Iran J Public Health. 2008;37(1):72–8.
19. Ataie-Jafari A, Qorbani M, Heshmat R, Ardalan G, Motlagh ME, Asayesh H, et al. The association of vitamin D deficiency with psychiatric distress and violence behaviors in Iranian adolescents: the CASPIAN-III study. J Diabetes Metab Disord. 2015;14:62. - DOI - PubMed - PMC
20. Husmann C, Frank M, Schmidt B, Jöckel KH, Antel J, et al. Low 25(OH)-vitamin D concentrations are associated with emotional and behavioral problems in German children and adolescents. PLoS One. 2017;12(8):83091. - DOI
21. Robinson SL, Marín C, Oliveros H, Mora-Plazas M, Lozoff B, Villamor E. Vitamin D deficiency in middle childhood is related to behavior problems in adolescence. J Nutr. 2020;150(1):140–8. - DOI - PubMed
22. Ssegonja R, Sampaio F, Alaie I, Philipson A, Hagberg L, Murray K, et al. Cost-effectiveness of an indicated preventive intervention for depression in adolescents: a model to support decision making. J Affect Disord. 2020;277:789–99. - DOI - PubMed
23. Kolovos S, Bosmans JE, van Dongen JM, van Esveld B, Magai D, van Straten A, et al. Utility scores for different health states related to depression: individual participant data analysis. Qual Life Res. 2017;26(7):1649–58. - DOI - PubMed - PMC
24. Goudarzi R, Zeraati H, Akbari Sari A, Rashidian A, Mohammad K. Population-based preference weights for the EQ-5D health states using the Visual Analogue Scale (VAS) in Iran. Iran Red Crescent Med J. 2016;18(2): e21584. - DOI - PubMed - PMC
25. Goudarzi R, Sari AA, Zeraati H, Rashidian A, Mohammad K, Amini S. Valuation of quality weights for EuroQol 5-dimensional health states with the time trade-off method in the capital of Iran. Value Health Reg Issues. 2019;18:170–5. - DOI - PubMed
26. Kelishadi R, Majdzadeh R, Motlagh ME, Heshmat R, Aminaee T, Ardalan G, et al. Development and evaluation of a questionnaire for assessment of determinants of weight disorders among children and adolescents: the Caspian-IV study. Int J Prev Med. 2012;3(10):699–705. - PubMed - PMC
27. CBotIRo I. Central Bank of the Islamic Republic of Iran. 2018. https://www.cbiir/Inflation/Inflation_enaspx .
28. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
29. Weinstein MC, Torrance G, McGuire A. QALYs: the basics. Value Health. 2009;12(Suppl 1):S5-9. - DOI - PubMed
30. Moradi N, Rashidian A, Nosratnejad S, Olyaeemanesh A, Zanganeh M, Zarei L. Willingness to pay for one quality-adjusted life year in Iran. Cost Eff Resour Alloc. 2019;17:4. - DOI - PubMed - PMC
31. Rascati KL. Essentianls of pharmacoeconomics. 2009.
32. Rafraf M, Hasanabad SK, Jafarabadi MA. Vitamin D status and its relationship with metabolic syndrome risk factors among adolescent girls in Boukan Iran. Public Health Nutr. 2014;17(4):803–9. - DOI - PubMed
33. Kelishadi R, Qorbani M, Motlagh ME, Heshmat R, Poursafa P, Bahreynian M. Prevalence of vitamin D deficiency according to climate conditions among a nationally representative sample of Iranian adolescents: the CASPIAN-III study. Int J Pediatr. 2016;4(6):1903–10.
34. Ghazizadeha A. Cost-Benefit Analysis of Treatment of Depressed Patients in Health System of Kurdistan Province in 1993. Sci J Kurdistan Univ Med Sci. 2001;5(3):14.
35. Goudarzi R, Zeraati H, Sari AA, Rashidian A, Mohammad K. Population-based preference weights for the EQ-5D health states using the visual analogue scale (VAS) in Iran. Iran Red Crescent Med J. 2016;18(2):e21584. - DOI - PubMed - PMC
36. Kuchay MS, Jevalikar GS, Mithal A, Mishra SK, Dang N. Efficacy and safety of a single monthly dose of cholecalciferol in healthy school children. J Pediatr Endocrinol Metab. 2016;29(4):413–6. - DOI - PubMed
37. Ataie-Jafari A, Qorbani M, Heshmat R, Ardalan G, Motlagh ME, Asayesh H, et al. The association of vitamin D deficiency with psychiatric distress and violence behaviors in Iranian adolescents: the CASPIAN-III study. J Diabetes Metab Disord. 2015;14(1):1–11. - DOI
38. Ghazizadeh A. Cost-benefit analysis of treatment of depressed patients in health system of Kurdistan province in 1993. 2001.

---

20+ VitaminDWiki pages have COST-EFFECTIVE in the title

This list is automatically updated